Indeed, RT inhibitors are efficacious in IFN-driven systemic inflammation observed in the Trex1-/- (a DNase) mouse model of AGS (143) and reduce the IFN signature in patients with AGS (145). The gene discussed is IFNA1; the disease is Aicardi-Goutieres syndrome.